Hologic Inc (HOLX) support and resistance · P/E 32, rev $4.10B
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
This page maps Hologic Inc (HOLX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new HOLX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the HOLX quote page for the session range and the stock page for the full model.
Not investment advice.